Company Filing History:
Years Active: 2025
Title: Seunghui Sin: Innovator in Crystalline Salt Technology
Introduction
Seunghui Sin is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of chemical engineering, particularly in the development of innovative pharmaceutical compounds. His work has led to the creation of a unique crystalline salt of eribulin, which has implications for cancer treatment.
Latest Patents
Seunghui Sin holds a patent for a crystalline salt of eribulin. This invention involves an eribulin salt formed by combining an eribulin free base with a low molecular weight amine compound through a diacid compound. The diacid compounds that may be employed include edisylic acid, 1,5-naphthalenedisulfonic acid, trans-2-butene-1,4-dicarboxylic acid, and pyrophosphoric acid. The amine compounds used can be ammonia, cyclohexylamine, dicyclohexylamine, or combinations thereof. The eribulin salt can be crystallized through recrystallization, resulting in a crystalline eribulin salt with increased purity.
Career Highlights
Seunghui Sin is currently employed at Yonsung Fine Chemical Co., Ltd., where he continues to innovate in the field of chemical compounds. His work has been instrumental in advancing the understanding and application of eribulin salts in pharmaceuticals.
Collaborations
Seunghui collaborates with talented coworkers, including Areum Baek and Hyunik Shin. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Seunghui Sin is a prominent inventor whose work on crystalline salts has the potential to impact cancer treatment significantly. His innovative approach and collaboration with skilled colleagues highlight the importance of teamwork in scientific advancements.